RadNet Inc RDNT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $56.71
- Day Range
- $56.88–59.34
- 52-Week Range
- $50.76–85.84
- Bid/Ask
- $52.08 / $59.00
- Shares Outstanding
- 78.63M
- Market Cap
- $4.49B
- Volume/Avg
- 840,825 / 819,068
Key Statistics
- Price/Earnings (Normalized)
- 151.89
- Price/Sales
- 2.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 11,264
- Website
- https://www.radnet.com
Valuation
|
Metric
|
RDNT
|
|---|---|
Price/Earnings (Normalized) | 151.89 |
Price/Book Value | 4.12 |
Price/Sales | 2.01 |
Price/Cash Flow | 13.43 |
Price/Earnings
RDNT
Financial Strength
|
Metric
|
RDNT
|
|---|---|
Quick Ratio | 1.06 |
Current Ratio | 1.17 |
Interest Coverage | 1.46 |
Quick Ratio
RDNT
Profitability
|
Metric
|
RDNT
|
|---|---|
Return on Assets (Normalized) | 2.14% |
Return on Equity (Normalized) | 7.68% |
Return on Invested Capital (Normalized) | 4.04% |
Return on Assets
RDNT
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Ssvkhbdb | Nwr | $174B | |||
| Danaher Corp
DHR
| Wvfsytlcx | Btcvr | $127B | |||
| IDEXX Laboratories Inc
IDXX
| Kdhxllvptw | Vvqr | $44B | |||
| Agilent Technologies Inc
A
| Sbcrlpdkcq | Hdp | $37B | |||
| Waters Corp
WAT
| Fxggytp | Njbtv | $35B | |||
| IQVIA Holdings Inc
IQV
| Xckgblmt | Slxlqq | $30B | |||
| Illumina Inc
ILMN
| Fpysdbm | Rpcnxx | $24B | |||
| Mettler-Toledo International Inc
MTD
| Qhpdvzdbp | Rjbhl | $23B | |||
| Quest Diagnostics Inc
DGX
| Bdtjjlbmd | Flghy | $22B | |||
| Labcorp Holdings Inc
LH
| Mcqbdxkkt | Wyhrk | $22B |
United States